Management

Highly experienced and successful team of industry experts

Ahmad Doroudian, PhD

Ahmad Doroudian, PhD

Chief Executive Officer

  • 20+ years experience as a Pharma CEO in finance, including M&A, and multiple IPOs, Integration of pharmaceutical operations (Whitehall Robbins, Rhone Polenc, Boehringer, Aventis)
  • Founder of Merus Labs (NASDAQ: MSLI), sold for $300 M+ in 2017
  • Acquisition, integration, tech transfer and management of branded pharmaceutical products Enablex®/Emselex®, Entrophen®, Sandomigran®, Sintrom®, Vancocin®, Zaditen®

 

Hooshmand Sheshbaradaran, PhD

Hooshmand Sheshbaradaran, PhD

Chief Operating Officer

  • 30+ years senior pharma executive with experience in global drug development, marketing, business strategy, operations, licensing and M&A
  • Senior executive roles at Pharmacia/Pfizer, Roche, Zeneus/Cephalon, Niiki Pharma, Psioxus
  • Development of Camptosar®, Ellence®, Emcyt®, Sutent® and Vidaza®.

               

Angela Ogden, MD

Angela Ogden, MD

Chief Medical Officer

  • 25+ year senior executive-level experience developing therapeutics from preclinical to launch including several blockbusters; plus 10+ years senior level academic medicine experience.
  • Senior executive roles at Pharmacia/Pfizer, BMS, JNJ, BTG
  • Development of Abraxane®, Aromasin®, Celebrex®, Dacogen®, Erbitux®, Folotyn®, TheraSphere®, Varithena®, Velcade®

                

Joseph Lamendola, PhD

Joseph Lamendola, PhD

Regulatory Strategy Advisor

  • 30+ years senior executive-level experience in pharma global regulatory from pre-IND to NDA
  • Executive roles at Schering Plough / Merck; BMS; Biopharmaceutical Practice
  • Filed and approved near 30 NDAs in ten different therapeutic areas

                

Moira Ong, CPA

Moira Ong, CPA

Chief Financial Officer

  • 18+ years experience as controller and CFO in several private and public companies including Merus Labs (NASDAQ: MSLI), and Pivot Pharmaceuticals (CSE: PVOT)
  • Managed the integration of the supply chain management and accounting Vancocin, Enablex®/Emselex®, acquired from Novartis, by Merus Labs International Inc.
  • Previously at Grant Thornton and Deloitte

                        

Terri Hinkley, EdD (c), MBA, BScN, RN

Terri Hinkley, EdD (c), MBA, BScN, RN

Head Clinical Operations

  • 20+ years of global clinical operations experience
  • CEO at Academy of Medical-Surgical Nurses (AMSN) and Medical Surgical Nursing Certification Board (MSNCB)